Javascript must be enabled to continue!
Environmental contamination with carbapenem resistant Acinetobacter baumannii in healthcare settings in Fiji: a potential source of infection
View through CrossRef
IntroductionThere are multiple ongoing outbreaks of carbapenem resistant Acinetobacter baumannii (CRAb) infection in Fiji’s hospitals. CRAb is able to colonize and persist on various hospital surfaces for extended periods. We conducted a study to understand the extent of hospital environmental contamination and phylogenetic links with clinical isolates.MethodsSwabs were collected from high-touch surfaces at Colonial War Memorial Hospital (CWMH) September 2021 and December 2022; Lautoka Hospital (LTKH) August 2022; and Labasa Hospital (LBSH) November 2022. All bacterial isolates were identified, and antimicrobial susceptibility testing (AST) performed; isolates resistant to carbapenems and producing a carbapenemase underwent whole genome sequencing. Comparison was made to clinical isolates obtained from CWMH in 2016–2017 and 2019–2021 and from LTKH and LBSH from 2020–2021.ResultsFrom the 180 environmental samples collected, ten (5.6%) CRAb were isolated; no other carbapenem-resistant gram-negative organisms were isolated. Seven (70%) of the CRAb were isolated from CWMH and three (30%) from LTKH; no CRAb were isolated from LBSH. Of the seven CWMH CRAb, two were sequence type 2 (ST2), three ST25, and two ST499. All LTKH isolates were ST499. The two environmental CRAb ST2 isolates were closely genetically linked to isolates obtained from patients in CWMH, LTKH, and LBSH 2020–2021. Similarly, the three environmental CRAb ST25 isolates were closely genetically linked to isolates obtained from patients admitted to CWMH in 2019–2021 and LBSH in 2020. The environmental CRAb ST499 isolates represented two distinct clones, with clone 1 comprising two genetically identical isolates from CWMH and clone 2 the three isolates from LTKH. Although no genetic linkages were observed when comparing environmental ST499 isolates to those from CWMH patients in 2020–2021, both clone 1 isolates were genetically identical to an isolate obtained from a patient admitted during the sampling period.ConclusionOur study highlights the contamination of high-touch surfaces within Fiji hospitals with CRAb, suggesting that these may serve as important sources for CRAb. Phylogenetic linkages to CRAb isolated from patients since 2019 underscores the persistence of this resistant pathogen in hospital settings and the ongoing risk for hospital-acquired infections.
Title: Environmental contamination with carbapenem resistant Acinetobacter baumannii in healthcare settings in Fiji: a potential source of infection
Description:
IntroductionThere are multiple ongoing outbreaks of carbapenem resistant Acinetobacter baumannii (CRAb) infection in Fiji’s hospitals.
CRAb is able to colonize and persist on various hospital surfaces for extended periods.
We conducted a study to understand the extent of hospital environmental contamination and phylogenetic links with clinical isolates.
MethodsSwabs were collected from high-touch surfaces at Colonial War Memorial Hospital (CWMH) September 2021 and December 2022; Lautoka Hospital (LTKH) August 2022; and Labasa Hospital (LBSH) November 2022.
All bacterial isolates were identified, and antimicrobial susceptibility testing (AST) performed; isolates resistant to carbapenems and producing a carbapenemase underwent whole genome sequencing.
Comparison was made to clinical isolates obtained from CWMH in 2016–2017 and 2019–2021 and from LTKH and LBSH from 2020–2021.
ResultsFrom the 180 environmental samples collected, ten (5.
6%) CRAb were isolated; no other carbapenem-resistant gram-negative organisms were isolated.
Seven (70%) of the CRAb were isolated from CWMH and three (30%) from LTKH; no CRAb were isolated from LBSH.
Of the seven CWMH CRAb, two were sequence type 2 (ST2), three ST25, and two ST499.
All LTKH isolates were ST499.
The two environmental CRAb ST2 isolates were closely genetically linked to isolates obtained from patients in CWMH, LTKH, and LBSH 2020–2021.
Similarly, the three environmental CRAb ST25 isolates were closely genetically linked to isolates obtained from patients admitted to CWMH in 2019–2021 and LBSH in 2020.
The environmental CRAb ST499 isolates represented two distinct clones, with clone 1 comprising two genetically identical isolates from CWMH and clone 2 the three isolates from LTKH.
Although no genetic linkages were observed when comparing environmental ST499 isolates to those from CWMH patients in 2020–2021, both clone 1 isolates were genetically identical to an isolate obtained from a patient admitted during the sampling period.
ConclusionOur study highlights the contamination of high-touch surfaces within Fiji hospitals with CRAb, suggesting that these may serve as important sources for CRAb.
Phylogenetic linkages to CRAb isolated from patients since 2019 underscores the persistence of this resistant pathogen in hospital settings and the ongoing risk for hospital-acquired infections.
Related Results
Prevalence and mechanism of carbapenem-resistant genes in Acinetobacter baumannii
Prevalence and mechanism of carbapenem-resistant genes in Acinetobacter baumannii
Abstract
BackgroundGram-negative Acinetobacter baumannii is an opportunistic pathogen, being highly reported for causing various nosocomial infections worldwide. The presen...
Gambaran Klinis dan Laboratorium Kejadian Resistensi Karbapenem Bakteri Acinetobacter Baumannii
Gambaran Klinis dan Laboratorium Kejadian Resistensi Karbapenem Bakteri Acinetobacter Baumannii
Abstract. Antimicrobial Resistance Collaborators mentioned there are six main pathogens in antibiotic resistance cases, including Acinetobacter baumannii. This study aims to determ...
Prevalensi Gen OXA-23 pada Isolat Klinis Bakter Acinetobacter baumanii di RSUP Dr. M. Djamil Padang
Prevalensi Gen OXA-23 pada Isolat Klinis Bakter Acinetobacter baumanii di RSUP Dr. M. Djamil Padang
Acinetobacter baumannii is such a big challenge in this modern era because of their multi-drug resistance (MDR) through their resistance mechanism, namely the production of beta la...
Analysis of the Infection status and risk Factors of carbapenem-resistant Acinetobacter baumannii in children
Analysis of the Infection status and risk Factors of carbapenem-resistant Acinetobacter baumannii in children
[Abstract]
Objective
To analyze the clinical characteristics of Acinetobacter baumannii infection in hospitalized children in a...
Carbapenem-resistant Acinetobacter baumannii in Latin America
Carbapenem-resistant Acinetobacter baumannii in Latin America
Acinetobacter baumannii is an important bacterial pathogen associated with healthcare-associated infections (HAIs), especially in critically ill patients admitted to Intensive Care...
One-year molecular surveillance of carbapenem-susceptible A. baumannii on a German intensive care unit: diversity or clonality
One-year molecular surveillance of carbapenem-susceptible A. baumannii on a German intensive care unit: diversity or clonality
Abstract
Background
A. baumannii is a common nosocomial pathogen known for its high transmission potential. A high rate of carbapenem-susceptible Ac...
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Abstract
Introduction
Hospitals are high-risk environments for infections. Despite the global recognition of these pathogens, few studies compare microorganisms from community-acqu...
Burden of carbapenem-resistant Acinetobacter baumannii involved in ventilator-associated pneumonia
Burden of carbapenem-resistant Acinetobacter baumannii involved in ventilator-associated pneumonia
Objectives:
Ventilator-associated pneumonia (VAP) is the most prevalent nosocomial infection of the intensive care unit (ICU) of any hospital, which accounts for more than 25% of a...

